FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+4.61%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$289M
AUM Growth
+$289M
(-7.8%)
Cap. Flow
-$9.55M
Cap. Flow
% of AUM
-3.31%
Top 10 Holdings %
Top 10 Hldgs %
86.15%
Holding
22
New
–
Increased
9
Reduced
6
Closed
1
Top Buys
1 |
Larimar Therapeutics
LRMR
|
$4.26M |
2 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$3.44M |
3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$2.48M |
4 |
EPZM
Epizyme, Inc
EPZM
|
$2.4M |
5 |
NVET
Nexvet Biopharma plc Ordinary Shares
NVET
|
$565K |
Top Sells
Sector Composition
1 | Healthcare | 67.65% |